New: NCI-funded clinical trial search
Mednet Logo

Do you routinely hold SGLT2 inhibitors prescribed for CHF or CKD in acutely ill patients upon admission to the hospital?

If so, how do you decide when to restart the medication?
Community PollStarted

Do you hold SGLT2 inhibitors prescribed for CHF or CKD in acutely ill patients upon admission to the hospital?

127 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet MemberInvited Expert
General Internal Medicine · University of Chicago
Answered on

Thanks for this great question. The use of SGLT2 inhibitors in the hospital has been increasing dramatically, given their great effects on CKD and CHF for both diabetic and non-diabetic patients. There are simple direct contraindications for using SGLT2s, which would include patients with ketosis in the urine or the blood and infections along the urinary tract, including cystitis and pyelonephritis.

Apart from this, the biggest risk in continuing in the hospital during acute illness comes in the setting of provoking euglycemic ketoacidosis. This comes when there is a risk of a prolonged NPO period. In the hospital, this comes around procedures for which patients are made NPO for the procedure. Typically, SGLT2 inhibitors should be held 3-4 ...

Join for free or sign in to see the full answer